Digoxin: Review of Current Laboratory Practice and Considerations

Q1 Biochemistry, Genetics and Molecular Biology Clinical Biochemist Reviews Pub Date : 2023-01-01 DOI:10.33176/aacb-22-00002
O. Treacy
{"title":"Digoxin: Review of Current Laboratory Practice and Considerations","authors":"O. Treacy","doi":"10.33176/aacb-22-00002","DOIUrl":null,"url":null,"abstract":"Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its narrow therapeutic index, with toxicity and therapeutic levels being relatively close. Clinically, digoxin toxicity can be acute or chronic, and can manifest with signs and symptoms related to the gastrointestinal system, nervous system, and cardiovascular system. Given digoxin toxicity can lead to fatal dysrhythmias, accurate and reproducible analysis by the laboratory is essential in the treatment of patients with suspected digoxin toxicity. However, the laboratory workup for digoxin toxicity is not as simple as performing a digoxin level. Other factors such as cross-reacting molecules, the effect of other biochemical findings, and the effect of the digoxin antidote (anti-digoxin antibody fragments) on immunoassay results need to be considered in clinical settings where the results aren’t consistent with clinical findings. The laboratory is ideally placed to help with issues relating from these factors to digoxin level interpretation.","PeriodicalId":34924,"journal":{"name":"Clinical Biochemist Reviews","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Biochemist Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33176/aacb-22-00002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Digoxin is a drug used for its effects on the heart, particularly its effect on rate and strength of contraction. Levels are particularly useful in clinical practice owing to its narrow therapeutic index, with toxicity and therapeutic levels being relatively close. Clinically, digoxin toxicity can be acute or chronic, and can manifest with signs and symptoms related to the gastrointestinal system, nervous system, and cardiovascular system. Given digoxin toxicity can lead to fatal dysrhythmias, accurate and reproducible analysis by the laboratory is essential in the treatment of patients with suspected digoxin toxicity. However, the laboratory workup for digoxin toxicity is not as simple as performing a digoxin level. Other factors such as cross-reacting molecules, the effect of other biochemical findings, and the effect of the digoxin antidote (anti-digoxin antibody fragments) on immunoassay results need to be considered in clinical settings where the results aren’t consistent with clinical findings. The laboratory is ideally placed to help with issues relating from these factors to digoxin level interpretation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
地高辛:当前实验室实践和考虑的回顾
地高辛是一种对心脏有影响的药物,特别是对收缩速度和强度的影响。由于其治疗指数较窄,毒性和治疗水平相对接近,因此在临床实践中特别有用。临床上地高辛毒性可分为急性或慢性,可表现为与胃肠道系统、神经系统和心血管系统相关的体征和症状。鉴于地高辛毒性可导致致命的心律失常,在治疗疑似地高辛毒性的患者时,实验室进行准确和可重复的分析至关重要。然而,地高辛毒性的实验室检查并不像进行地高辛水平检测那么简单。其他因素,如交叉反应分子、其他生化结果的影响以及地高辛解毒剂(抗地高辛抗体片段)对免疫测定结果的影响,在临床结果与临床结果不一致的情况下,需要考虑。实验室是帮助解决这些因素与地高辛水平解释相关问题的理想场所。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Biochemist Reviews
Clinical Biochemist Reviews Biochemistry, Genetics and Molecular Biology-Clinical Biochemistry
自引率
0.00%
发文量
0
期刊最新文献
Digital Disruption in Healthcare and its Impact on Laboratory Services Standardisation of Dietary and Medication Restrictions for Urine 5-Hydroxyindoleacetic Acid (5-HIAA) Collection Diagnostic Evaluation of Renal Tubular Acidosis: A Clinical Biochemistry Perspective Digoxin: Review of Current Laboratory Practice and Considerations Proceedings of the Australasian Association of Clinical Biochemistry and Laboratory Medicine's 2021 Virtual Scientific Conference.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1